InvestorsHub Logo
Followers 27
Posts 5124
Boards Moderated 0
Alias Born 01/27/2014

Re: None

Friday, 10/21/2016 8:12:28 AM

Friday, October 21, 2016 8:12:28 AM

Post# of 43716
CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial

Source: Business Wire
CEL-SCI Corporation (NYSE MKT:CVM) announced today: following up on our press release issued on September 26, 2016, we have received the Partial Clinical Hold letter from the U.S. Food and Drug Administration (FDA). CEL-SCI has started working on a response to the FDA and will work diligently with the FDA to seek to have the partial clinical hold lifted.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News